“Deucravacitinib in Plaque Psoriasis: 2-Year Laboratory Results from the Phase 3 POETYK PSO Program”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s46. https://doi.org/10.25251/skin.6.supp.46.